Updated on 11 April 2014
This led to Germany and France suspending the medicine and thousands of patients taking legal action against both the companies.
"We have empathy for the Allens, but we believe the evidence did not support a finding that Actos caused his bladder cancer. We also believe we demonstrated that Takeda acted responsibly with regard to Actos," a Takeda laywer, Mr Kenneth Greisman said.
Last year, state juries in California and Maryland ordered Takeda to pay a total of $8.2 million in damages to former Actos users, but judges in both states threw out the verdicts.